Suono Bio

Cambridge, United States Founded: 2015 • Age: 11 yrs
Developer of technology to enable ultra-rapid delivery of therapeutics to the gastrointestinal tract

About Suono Bio

Suono Bio is a company based in Cambridge (United States) founded in 2015 by Giovanni Traverso.. Suono Bio has raised $12.68 million across 5 funding rounds from investors including Fujifilm, Axil Capital and Mizuho Securities. Suono Bio offers products and services including Proprietary Delivery Platform. Suono Bio operates in a competitive market with competitors including Ensysce, Oxular, Arecor, EryDel and PharmaJet, among others.

  • Headquarter Cambridge, United States
  • Founders Giovanni Traverso
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $12.68 M (USD)

    in 5 rounds

  • Latest Funding Round
    $500 K (USD), Series B

    Aug 25, 2023

  • Investors
    Fujifilm

    & 6 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Suono Bio

Suono Bio offers a comprehensive portfolio of products and services, including Proprietary Delivery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Platform enables targeted treatments for gastrointestinal diseases using innovative technology.

People of Suono Bio
Headcount 10-50
Employee Profiles 3
Board Members and Advisors 5
Employee Profiles
People
Albert Farinha
COO
People
Scott Kellogg
Member Bod / Chief Executive Officer
People
Sean Moran
Senior Management Advisor

Unlock access to complete

Board Members and Advisors
people
David Feigal
Medical Advisor
people
Fred Shane
Director
people
Kenolisa Onwueme
Advisor
people
Jakob Begun
Medical Advisor

Unlock access to complete

Funding Insights of Suono Bio

Suono Bio has successfully raised a total of $12.68M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $500 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series B — $500,000
  • First Round
  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2023 Amount Series B - Suono Bio Valuation

investors

Jul, 2021 Amount Series B - Suono Bio Valuation Axil Capital , Mizuho Securities
Apr, 2020 Amount Series A - Suono Bio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Suono Bio

Suono Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Fujifilm, Axil Capital and Mizuho Securities. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage investments are targeted by Axil Capital, a VC firm.
Founded Year Domain Location
VC firm focusing on technology companies
Founded Year Domain Location
Innovative ideas are transformed into reality by Niterra Ventures.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Suono Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Suono Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Suono Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Suono Bio

Suono Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ensysce, Oxular, Arecor, EryDel and PharmaJet, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Drug delivery solutions via single-walled carbon nanotubes are offered.
domain founded_year HQ Location
Drug delivery platforms and therapeutics for ophthalmology are developed.
domain founded_year HQ Location
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
domain founded_year HQ Location
Erythrocyte encapsulation systems for drug delivery are developed.
domain founded_year HQ Location
Provider of needle-free injection technology
domain founded_year HQ Location
Provider of a proprietary platform for gene therapy
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Suono Bio

When was Suono Bio founded?

Suono Bio was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is Suono Bio located?

Suono Bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Is Suono Bio a funded company?

Suono Bio is a funded company, having raised a total of $12.68M across 5 funding rounds to date.

What does Suono Bio do?

Suono Bio was founded in 2015 in Cambridge, United States, with technology initiated in MIT research laboratories. Focus is placed on developing a device that enables ultra-rapid delivery of therapeutics to the gastrointestinal tract. Applications include treatments for inflammatory bowel disease, cancer, and infectious GI conditions. Operations center on biotechnology and medical device sectors within the United States.

Who are the top competitors of Suono Bio?

Suono Bio's top competitors include Oxular, PharmaJet and Splice Bio.

What products or services does Suono Bio offer?

Suono Bio offers Proprietary Delivery Platform.

Who are Suono Bio's investors?

Suono Bio has 7 investors. Key investors include Fujifilm, Axil Capital, Mizuho Securities, Taiwania Capital, and Niterra Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available